Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.

Yu HanLin-Feng YanXi-Bin WangYing-Zhi SunXin ZhangZhi-Cheng LiuHai-Yan NanYu-Chuan HuYang YangJin ZhangYing YuQian SunQiang TianBo HuGang XiaoWen WangGuang-Bin Cui

Published in: BMC cancer (2018)

ADC and rCBF are promising imaging biomarkers in clinical routine to predict the MGMT promoter methylation in primary glioblastoma patients.

Keyphrases

dna methylation
high resolution
end stage renal disease
gene expression
transcription factor
genome wide
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
magnetic resonance imaging
clinical practice
patient reported outcomes
magnetic resonance
fluorescence imaging